Ret Proto-Oncogene anticorps (C-Term)
(1 reference)-
- Antigène Voir toutes Ret Proto-Oncogene (RET) Anticorps
- Ret Proto-Oncogene (RET)
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Ret Proto-Oncogene est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Fonction
- Rabbit polyclonal antibody raised against synthetic peptide of RET.
- Réactivité croisée
- Humain
- Immunogène
- A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human RET.
- Top Product
- Discover our top product RET Anticorps primaire
-
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reactivité: Humain IHC, StM Hôte: Souris Monoclonal RET-2795 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1-1072) antibodyRET Reactivité: Humain WB, PLA Hôte: Lapin Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibodyRET Reactivité: Humain ELISA, Coat Hôte: Souris Monoclonal RET-2663 unconjugated
anti-Ret Proto-Oncogene (RET) antibodyRET Reactivité: Humain WB Hôte: Lapin Monoclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 152-182), (N-Term) antibodyRET Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB00705 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1012-1042), (C-Term) antibodyRET Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB01561 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 361-458) antibodyRET Reactivité: Humain WB, ELISA, PLA Hôte: Souris Monoclonal 1A5 unconjugated
anti-Ret Proto-Oncogene (RET) (C-Term) antibodyRET Reactivité: Humain, Souris, Rat WB, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (pTyr1062) antibodyRET Reactivité: Humain, Souris, Rat WB, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 29-300) antibodyRET Reactivité: Humain WB, IHC, IF Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:50-100)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In PBS (0.09 % sodium azide)
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma." dans: Nucleic acids research, Vol. 36, Issue 1, pp. e2, (2008) (PubMed).
-
: "siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma." dans: Nucleic acids research, Vol. 36, Issue 1, pp. e2, (2008) (PubMed).
-
- Antigène
- Ret Proto-Oncogene (RET)
- Autre désignation
- RET (RET Produits)
- Synonymes
- anticorps c-ret, anticorps cret, anticorps etID315074.13, anticorps ret1, anticorps wu:fd13h01, anticorps X-ret, anticorps ret-A, anticorps xret, anticorps RET, anticorps MTC1, anticorps CDHF12, anticorps CDHR16, anticorps HSCR1, anticorps MEN2A, anticorps MEN2B, anticorps PTC, anticorps RET-ELE1, anticorps RET51, anticorps RET9, anticorps c-Ret, anticorps ret proto-oncogene receptor tyrosine kinase, anticorps ret proto-oncogene S homeolog, anticorps ret proto-oncogene, anticorps ret, anticorps ret.S, anticorps RET, anticorps Ret
- ID gène
- 5979
- Pathways
- Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-
